Ontology-supported research on vaccine efficacy, safety and integrative biological networks

Expert Review of Vaccines

Volumn 13, Issue 7, 2014, Pages 825-841

  He, Yongqun ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

adverse event; data mining; interaction network; literature mining; meta analysis; ontology; theory; vaccine; vaccine efficacy; vaccine safety

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; SMALLPOX VACCINE; VACCINE; YELLOW FEVER VACCINE; 4CMENB VACCINE; BRUCELLA VACCINE; MENINGOCOCCUS VACCINE;

ADAPTIVE IMMUNITY; COMPUTER MODEL; DATA BASE; DATA MINING; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GENE INTERACTION; HUMAN; IMMUNE RESPONSE; MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES; MEDICAL ONTOLOGY; META ANALYSIS (TOPIC); MOLECULAR INTERACTION; NATURAL LANGUAGE PROCESSING; ONTOLOGY; ONTOLOGY DEVELOPMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VACCINATION; BIOLOGICAL ONTOLOGY; COMPUTER SIMULATION; DRUG DESIGN; FACTUAL DATABASE; IMMUNOLOGY; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; STATISTICAL ANALYSIS;

BIOLOGICAL ONTOLOGIES; BRUCELLA VACCINE; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DRUG DESIGN; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; VACCINES;

EID: 84902341834     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.923762     Document Type: Review

References (82)

1. He Y, Rappuoli R, De Groot AS, Chen RT. Emerging vaccine informatics. J Biomed Biotechnol 2010;2010:218590.
2. Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by wholegenome sequencing. Science 2000;287(5459):1816-20
3. Althoff E, Gassenbach N. Novartis submits Bexsero-, a multi-component meningococcal B vaccine, for regulatory review in Europe. Novartis Media releases, USA; 2010. Available from: www.novartis. com/newsroom/media-releases/ en/2010/1475256.shtml
4. He Y, Xiang Z, Mobley HL. Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol 2010;2010:297505
5. He Y, Xiang Z. Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN. Immunome Res 2010;6(Suppl 1): S5
6. Xiang Z, He Y. Vaxign: a web-based vaccine target design program for reverse vaccinology. Procedia Vaccinol 2009;1(1): 23-9
7. Gomez G, Pei J, Mwangi W, et al. Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approach. PLoS One 2013;8(3):e59751
8. He Y. Genome-based computational vaccine discovery by reverse vaccinology. In: Flower DR, editors. Immunomic discovery of adjuvants and candidate subunit vaccines. Springer; New York: 2013
9. Pereira UP, Soares SC, Blom J, et al. In silico prediction of conserved vaccine targets in Streptococcus agalactiae strains isolated from fish, cattle, and human samples. Genet Mol Res 2013;12(3):2902-12
10. Xiang Z, He Y. Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology. BMC Bioinformatics 2013;14(Suppl 4): S2.
11. Van Regenmortel MH. Basic research in HIV vaccinology is hampered by reductionist thinking. Front Immunol 2012;3:194
12. Hur J, Xiang Z, Feldman EL, He Y. Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network. BMC Immunol 2011;12:49
13. Bagnoli F, Baudner B, Mishra RP, et al. Designing the next generation of vaccines for global public health. OMICS 2011;15(9):545-66
14. He Y. Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics. Front Cell Infect Microbiol 2012;2:2
15. Sayers S, Ulysse G, Xiang Z, He Y. Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development. J Biomed Biotechnol 2012;2012:831486
16. Racz R, Li X, Patel M, et al. DNAVaxDB: the first web-based DNA vaccine database and its data analysis. BMC Bioinformatics 2014;15(Suppl 4):S2
17. Poland GA, Ovsyannikova IG, Jacobson RM. Application of pharmacogenomics to vaccines. Pharmacogenomics 2009;10(5):837-52.
18. Sarntivijai S, Xiang Z, Shedden KA, et al. Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines. PLoS One 2012;7(11):e49941.
19. Bonhoeffer J, Black S, Izurieta H, et al. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe. Biologicals 2012;40(5):393-7
20. Vaccine adverse event reporting system. Available from: www.vaers.hhs.gov
21. Chen RT, Rastogi SC, Mullen JR, et al. The vaccine adverse event reporting system (VAERS). Vaccine 1994;12(6):542-50
22. Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J 2004;23(4): 287-94 (Pubitemid 38508877)
23. Frequently asked questions. Available from: www.vaers.hhs.gov/about/faqs
24. Brown EG. Methods and pitfalls in searching drug safety databases utilising the medical dictionary for regulatory activities (MedDRA). Drug Saf 2003;26(3): 145-58 (Pubitemid 36313013)
25. Brown SH, Elkin PL, Bauer BA, et al. SNOMED CT: utility for a general medical evaluation template. AMIA Annu Symp Proc 2006:101-5
26. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009;10(1):57-63
27. Nakaya HI, Li S, Pulendran B. Systems vaccinology: learning to compute the behavior of vaccine induced immunity. Wiley Interdiscip Rev Syst Biol Med 2012; 4(2):193-205
28. Pulendran B, Li S, Nakaya HI. Systems vaccinology. Immunity 2010;33(4): 516-29
29. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12(8):786-95.
30. Poland GA, Ovsyannikova IG, Jacobson RM. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008;8(11):1659-67
31. Poland GA, Ovsyannikova IG, Kennedy RB, et al. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS 2011;15(9): 625-36
32. He Y, Xiang Z. Databases and in silico tools for vaccine design. Methods Mol Biol 2013;993:115-27
33. US FDA vaccines. Available from: www.fda. gov/BiologicsBloodVaccines/ Vaccines/default.htm
34. USDA veterinary biological products, licensees and permittees, prepared April 9, 2014. Available from: www.aphis.usda.gov/animal-health/vet-biologics/ publications/CurrentProdCodeBook.pdf terms.
35. Bioinformatics Oxford, England 2005;21(15):3324-6.
36. Osborne JD, Zhu LJ, Lin SM, Kibbe WA. Interpreting microarray results with gene ontology and MeSH. Methods Mol Biol 2007;377:223-42
37. Hur J, Schuyler AD, States DJ, Feldman EL. SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics Oxford, England 2009;25(6): 838-40
38. Genomesh. Available from: www.genomesh. hegroup.org
39. Xiang Z, Qin T, Qin Z, He Y. A genome-wide MeSH-based literature mining system predicts implicit gene-to-gene relationships and networks. BMC Syst Biol 2013;7(Suppl 3):S9
40. Joachims T. Making large-scale support vector machine learning practical. In: Schölkopf B CJB, Smola AJ, editors. Advances in kernel methods: support vector learning. MIT Press; Cambridge, MA: 1999. 169-84
41. Ozgur A, Xiang Z, Radev D, He Y. Literature-based discovery of IFN-g and vaccine-mediated gene interaction networks. J Biomed Biotechnol 2010;2010:article id 426479 426413
42. He Y, Xiang Z, Sarntivijai S, et al. AEO: a realism-based biomedical ontology for the representation of adverse events. In: Adverse Event Representation Workshop, International Conference on Biomedical Ontologies (ICBO-2011). CEUR Workshop Proceedings. 26-30 July 2011; Buffalo, NY, USA; Pages 309-15. Available from: www. ceur-ws.org/Vol-833/paper359.pdf
43. Marcos E, Zhao B, He Y. The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines. J Biomed Semantics 2013;4:40.
44. Lee JA, Spidlen J, Boyce K, et al. MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry A 2008;73(10):926-30
45. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29(4):365-71 (Pubitemid 34326681)
46. Todd TE, Tibi O, Lin Y, et al. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics 2013;14(Suppl 6):S3
47. Brinkman RR, Courtot M, Derom D, et al. Modeling biomedical experimental processes with OBI. J Biomed Semantics 2010; 1(Suppl 1):S7
48. He Y, Xiang Z, Todd T, et al. Ontology representation and ANOVA analysis of vaccine protection investigation. In: Bio-Ontologies 2010: Semantic Applications in Life Sciences: CEUR Workshop Proceedings, 11-13July 2010.Boston, MA, USA. Pages 1-8 Available from: www.ceurws. org/Vol-754/he-krmed2010.pdf]
49. Glass GV. Primary, secondary, and meta-analysis of research. Educ Res 1976;5: 3-8
50. Altman DG. Statistics in medical journals: some recent trends. Stat Med 2000;19(23): 3275-89
51. Lean IJ, Rabiee AR, Duffield TF, Dohoo IR. Invited review: use of meta-analysis in animal health and reproduction: methods and applications. J Dairy Sci 2009;92(8):3545-65
52. Lukk M, Kapushesky M, Nikkila J, et al. A global map of human gene expression. Nat Biotechnol 2010;28(4):322-4
53. Zheng-Bradley X, Rung J, Parkinson H, Brazma A. Large scale comparison of global gene expression patterns in human and mouse. Genome Biol 2010;11(12):R124
54. Bizer C, Heath T, Berners-Lee T. Linked Data-the story so far. Int J Semantic Web Information Systems 2009;5(3):22
55. Design issues: linked data. Available from: www.w3.org/DesignIssues/ LinkedData
56. Belleau F, Nolin MA, Tourigny N, et al. Bio2RDF: towards a mashup to build bioinformatics knowledge systems. J Biomed Inform 2008;41(5):706-16
57. Yamamoto Y, Yamaguchi A, Yonezawa A. Building linked open data towards integration of biomedical scientific literature with DBpedia. J Biomed Semantics 2013; 4(1):8
58. Grenon P, Smith B. SNAP and SPAN: towards dynamic spatial ontology. Spat Cogn Comput 2004;4(1):69-103
59. Futuyma DJ. Evolutionary Biology, 3rd edition: Sinauer Associates, USA 1997
60. Baluska F, Volkmann D, Barlow PW. Eukaryotic cells and their cell bodies: cell Theory revised. Ann Bot (Lond) 2004;94(1):9-32 (Pubitemid 41295569)
61. Mazzarello P. A unifying concept: the history of cell theory. Nat Cell Biol 1999;1(1):E13-15
62. Perelson AS. Immune network theory. Immunol Rev 1989;110:5-36 (Pubitemid 19216007)
63. Moore KL. Essentials of Human Embryology. B.C. Decker, Inc; Toronto, Canada: 1988
64. Friedman N, Linial M, Nachman I, Pe'er D . Using Bayesian networks to analyze expression data. J Comput Biol 2000; 7(3-4):601-20
65. He Y, Xiang Z. miniTUBA: a web-based dynamic Bayesian network analysis system and an application in host-pathogen interaction analysis. In: Rebai A, editors. Bayesian Network, Sciyo 2010. Available from: www.intechopen.com/ articles/show/title/minituba-a-web-based-dynamicbayesian-network-analysis-system
66. Hodges AP, Dai D, Xiang Z, et al. Bayesian network expansion identifies new ROS and biofilm regulators. PLoS One 2010;5(3): e9513
67. Pearl J. Causality. 2nd edition Cambridge University Press; New York, NY, USA: 2009
68. Croft D, O'Kelly G, Wu G, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 2011;39(Database issue):D691-7
69. Kanehisa M, Goto S, Kawashima S, et al. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32(Database issue):D277-80 (Pubitemid 38081656)
70. Latendresse M, Paley S, Karp PD. Browsing metabolic and regulatory networks with BioCyc. Methods Mol Biol 2012;804: 197-216
71. BioCarta apoptosis pathway. Available from: www.biocarta.com/genes/ Apoptosis.asp
72. HarshaRani GV, Vayttaden SJ, Bhalla US. Electronic data sources for kinetic models of cell signaling. J Biochem 2005;137(6):653-7 (Pubitemid 41003547)
73. He Y, Xiang Z. HINO: a BFO-aligned ontology representing human molecular interactions and pathways. arXiv 2013; arXiv:1311.3355.
74. DARPA: Big mechanism. DARPA Broad Agency Announcement 2014;DARPA-BAA-14-14
75. Hastings J, de Matos P, Dekker A, et al. The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013. Nucleic Acids Res 2013;41(Database issue):D456-63
76. Announcement of the ontology of genes and genomes (OGG). Available from: https://groups.google.com/forum/#!topic/ogg-discuss/wy0132CCdNA
77. Diehl AD, Augustine AD, Blake JA, et al. Hematopoietic cell types: prototype for a revised cell ontology. J Biomed Inform 2011;44(1):75-9
78. Sarntivijai S, Lin Y, Xiang Z, et al. CLO: the cell line ontology. J Biomed Semantics 2014;In press
79. Xiang Z, Lin Y, He Y. Ontorat web server for automatic generation and annotations of new ontology terms. In: The 3rd International Conference on Biomedical Ontologies (ICBO): CEUR Workshop Proceedings. 24-27July 2012; Graz, Austria;2012. Available from: www.ceur-ws. org/Vol-897/poster-812.pdf
80. Zheng J, Xiang Z, SJC J, et al. Ontodog: a web-based ontology community view generator. Bioinformatics 2013; In press
81. Tan PL, Jacobson RM, Poland GA, et al. Twin studies of immunogenicity-determining the genetic contribution to vaccine failure. Vaccine 2001;19(17-19): 2434-9 (Pubitemid 32234254)
82. The protege ontology editor. Available from: www.protege.stanford.edu/